ClinicalTrials.Veeva

Menu

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia

C

Center for Addiction and Mental Health (CAMH)

Status

Completed

Conditions

Healthy
Schizophrenia

Treatments

Procedure: Left cold CVS
Procedure: Left body temperature VS
Procedure: Right body temperature VS
Procedure: Left warm CVS
Procedure: Right cold CVS
Procedure: Right warm CVS

Study type

Interventional

Funder types

Other

Identifiers

NCT03048370
042-2016

Details and patient eligibility

About

This study aims to determine if individuals with schizophrenia have greater reactivity to vestibular stimulation than healthy controls. The physiological response of vestibular stimulation will be assessed with electronystagmography, which provides a measure of the intensity of the nystagmus via PSPV. Positive results would suggest greater vestibular system reactivity to vestibular stimulation may be a biomarker of schizophrenia. Pathophysiologically, increased vestibular reactivity to vestibular stimulation may reflect abnormal vestibular function or impaired central suppression of the vestibular ocular reflex.

Full description

In schizophrenia, there is no conclusive link between psychopathology and vestibular dysfunction and we are not aware of any data that exists on the range of responses to caloric vestibular stimulation (CVS) in persons with schizophrenia. Initial data from another CVS study from our group suggests individuals with schizophrenia have greater reactivity to body temperature (37°C) CVS, as measured by the peak slow phase velocity of the resulting nystagmus (PSPV), than would be expected from individuals without schizophrenia versus healthy participants. Intriguingly, CVS at 37°C should not theoretically produce a significant vestibulocular reflex response due to the stimulus' approximation to body temperature. Hence, the primary aim of this study is to determine if individuals with schizophrenia will have greater vestibular reactivity, as measured by nystagmus PSPV, to CVS in comparison with healthy participants. The secondary aim is to assess illness awareness pre and post CVS administration in attempts to replicate our previous observation. A total of 20 patients with schizophrenia and 20 healthy control participants will be recruited. All participants will receive three conditions bilaterally: (1) body temperature (37°C) vestibular stimulation; (2) warm CVS (44°C), and (3) cold CVS (30°C).

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Schizophrenia group:

  1. Male or female inpatients or outpatients age ≥18
  2. Having a DSM-5 diagnosis of schizophrenia or schizoaffective disorder
  3. Voluntary and capable of consenting to participation in the research study
  4. Fluent in English

Inclusion Criteria for Healthy Controls group:

  1. Male or female and age ≥18
  2. Voluntary and capable of consenting to participation in the research study
  3. Fluent in English
  4. Absence of history of psychiatric illness using the Mini-International Neuropsychiatric Interview (MINI)

Exclusion Criteria for all participants:

  1. Serious unstable medical illness or any concomitant major medical or neurological illness
  2. Acute suicidal and/or homicidal ideation
  3. Formal thought disorder rating of over 2 on the Scale for Assessment of Positive Symptoms (SAPS) [patients only]
  4. DSM-IV substance dependence (except caffeine and nicotine) within one month prior to entering the study
  5. Pregnant women
  6. Positive urine drug screen
  7. History of external or middle ear pathology
  8. History or signs of middle ear surgery (e.g. Tympanoplasty, mastoidectomy)
  9. Signs of active ear disease

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

40 participants in 6 patient groups

Left body temperature VS
Experimental group
Description:
Left body temperature (37°C) vestibular stimulation
Treatment:
Procedure: Left body temperature VS
Right body temperature VS
Experimental group
Description:
Right body temperature (37°C) vestibular stimulation
Treatment:
Procedure: Right body temperature VS
Left warm CVS
Experimental group
Description:
Left warm (44°C) caloric vestibular stimulation
Treatment:
Procedure: Left warm CVS
Right warm CVS
Experimental group
Description:
Right warm (44°C) caloric vestibular stimulation
Treatment:
Procedure: Right warm CVS
Left cold CVS
Experimental group
Description:
Left cold (30°C) caloric vestibular stimulation
Treatment:
Procedure: Left cold CVS
Right cold CVS
Experimental group
Description:
Right cold (30°C) caloric vestibular stimulation
Treatment:
Procedure: Right cold CVS

Trial contacts and locations

1

Loading...

Central trial contact

Philip Gerretsen, MD, PhD; Ariel Graff, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems